Parmar Kush

DirectorEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Aug 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2026Sell(S)92K$7.00$647K2.7M
Aug 7, 2026Sell(S)52K$6.85$358K2.8M
Aug 6, 2026Sell(S)10K$7.00$73K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001664281-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.